Roser Vento-Tormo was drawn to immunology by the simple question it poses: “How exactly do the cells of our body fight against the universe of pathogens we encounter every day?” For Vento-Tormo, a researcher in the Cellular Genetics program at the Wellcome...
Latest News
Breaking New Ground: Dr. Aleksandar Obradovic’s Research on Precision Immunotherapy Wins 2023 Michelson Prize
Dr. Aleksandar Obradovic's innovative approach to combining drugs to treat resistant cancer patients has earned him the prestigious 2023 Michelson Philanthropies & Science Prize for Immunology and $30,000. Dr. Obradovic, associate research scientist in the...
Breakthrough Discoveries in Human Immunology – Michelson Philanthropies and AAAS/Science Award Transformative Research
Michelson Philanthropies and AAAS/Science announce the recipients of the 2023 Michelson Philanthropies & Science Prize for Immunology. The grand prize is awarded to Dr. Aleksandar Obradovic; Dr. Roser Vento-Tormo and Dr. Joshua Tan receive finalist awards....
Pioneering a New Era of Intranasal Vaccinations: Dr. Brittany Hartwell’s Research is Recognized with 2022 Michelson Prize
Engineered to bypass mucosal barriers and improve mucosal uptake, Dr. Brittany Hartwell's intranasal vaccine promises stronger immune responses and immunity. The Michelson Medical Research Foundation and the Human Immunome Project have awarded one of the...
Oxford Researcher Romain Guyon Receives Michelson Prize for Work on Single-dose Rabies Vaccine
Oxford Ph.D. student Romain Guyon receives Michelson Prize for innovative work to create a single-dose rabies vaccine research. The Michelson Prize will give Guyon the opportunity to explore manufacturing methods, demonstrate the scale-up potential of the technology,...
Artificial Intelligence Meets Immunology: Dr. Noam Auslander, 2022 Michelson Prize Recipient, Brings a New Approach to Cancer Diagnosis and Treatment
Dr. Noam Auslander, Assistant Professor at The Wistar Institute, is revolutionizing AI and Immunology research with her work on detecting microbial expression in cancer and immune diseases. Dr. Noam Auslander’s work in artificial intelligence and...
Unlocking the Secrets of Immunity: Meet Dr. Jenna Guthmiller, 2022 Michelson Prize Recipient and Influenza Vaccine Innovator
Dedicated to improving vaccines and training the next generation of scientists, Dr. Jenna Guthmiller's research focuses on universal influenza vaccines and earns her a 2022 Michelson Prize. Jenna Guthmiller first learned about immunology growing up on her...
Michelson Prizes – Next Generation Grants: Advancing Immunology and Vaccine Innovation
This program features the recipients of the Michelson Prizes: Next Generation Grants, an international prize that supports early-career researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and...
The Next Generation of Global Health Innovators: Michelson Prize Winners Announced
Los Angeles/New York City — The Michelson Medical Research Foundation and the Human Immunome Project award Dr. Noam Auslander, Dr. Jenna Guthmiller, Romain Guyon, and Dr. Brittany Hartwell with the Michelson Prizes: Next Generation Grants. The $150,000...
Philanthropy’s Role in Advancing mRNA Technology
Maintaining mRNA’s momentum will require continued investment, effective collaboration, and philanthropic contributions, Dr. Thomas Conlon of Michelson Philanthropies said on a panel at the Milken Institute’s Future of Health Summit. Hundreds of medical...
Dr. Gary K. Michelson Returns to USC Michelson Center As It Celebrates Five Years
The USC Michelson Center for Convergent Bioscience is celebrating the fifth anniversary of its opening in 2017. Dr. Gary K. Michelson recently visited the center to learn about the latest research being conducted with state-of-the-art equipment. The USC...
Milken Institute Future of Health Summit: The Future of the mRNA Revolution
Michelson Philanthropies' Chief Scientific Officer Thomas Conlon joins the 2022 Milken Institute Future of Health Summit alongside a panel of vaccine development and biomedical experts to discuss the potential and advancements of mRNA. Messenger RNA, or mRNA, has been...